Celularity Historical Income Statement

CELU Stock

USD 2.76 0.09 3.16%

Historical analysis of Celularity income statement accounts such as Ebit of 17.2 M, Net Income Applicable To Common Shares of 17.1 M or Income Tax Expense of 15.7 K can show how well Celularity performed in making a profits. Evaluating Celularity income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Celularity's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Celularity latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Celularity is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Celularity. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.

About Celularity Income Statement Analysis

Celularity Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Celularity shareholders. The income statement also shows Celularity investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Celularity Income Statement Chart

At this time, Celularity's EBIT is comparatively stable compared to the past year. Net Income Applicable To Common Shares is likely to gain to about 17.1 M in 2024, whereas Selling General Administrative is likely to drop slightly above 48.1 M in 2024.

Selling General Administrative Selling And Marketing Expenses Total Revenue Other Operating Expenses

Total Revenue

Total revenue comprises all receipts Celularity generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Celularity. It is also known as Celularity overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from Celularity's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Celularity current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Celularity. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.At this time, Celularity's EBIT is comparatively stable compared to the past year. Net Income Applicable To Common Shares is likely to gain to about 17.1 M in 2024, whereas Selling General Administrative is likely to drop slightly above 48.1 M in 2024.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	159.7M	146.6M	99.3M	108.8M
Cost Of Revenue	9.7M	19.7M	16.0M	12.4M

Total Operating Expenses Cost Of Revenue

Celularity income statement Correlations

	Ebit	Income Tax Expense	Depreciation And Amortization	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Net Income From Continuing Ops	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Non Operating Income Net Other	Total Other Income Expense Net	Net Income	Tax Provision	Net Interest Income	Interest Income	Reconciled Depreciation
Ebit		0.33	0.31	0.25	-0.39	0.59	-0.4	0.27	0.09	-0.31	-0.11	0.85	0.67	0.17	0.1	-0.07	-0.2	0.09	0.53	0.15	-0.47	0.63
Income Tax Expense	0.33		0.14	0.83	-0.83	-0.24	-0.72	0.83	-0.73	-0.64	0.4	-0.21	0.65	0.83	-0.65	-0.84	-0.39	-0.65	0.77	-0.01	-0.61	0.73
Depreciation And Amortization	0.31	0.14		0.03	-0.17	-0.24	-0.48	0.18	0.27	-0.13	-0.51	0.25	0.43	0.01	-0.22	-0.17	-0.54	-0.22	0.08	0.39	-0.01	0.27
Selling General Administrative	0.25	0.83	0.03		-0.97	-0.22	-0.83	0.97	-0.85	-0.66	0.63	-0.2	0.79	0.99	-0.62	-0.95	-0.26	-0.63	0.94	0.07	-0.65	0.83
Selling And Marketing Expenses	-0.39	-0.83	-0.17	-0.97		0.12	0.86	-0.97	0.8	0.78	-0.44	0.05	-0.85	-0.95	0.69	0.93	0.45	0.69	-0.97	0.0	0.77	-0.93
Total Revenue	0.59	-0.24	-0.24	-0.22	0.12		0.38	-0.19	0.17	-0.18	-0.33	0.74	0.02	-0.31	0.29	0.43	0.01	0.28	0.08	-0.44	-0.26	0.06
Gross Profit	-0.4	-0.72	-0.48	-0.83	0.86	0.38		-0.83	0.46	0.44	-0.42	-0.02	-0.91	-0.83	0.45	0.83	0.32	0.45	-0.8	-0.47	0.47	-0.84
Other Operating Expenses	0.27	0.83	0.18	0.97	-0.97	-0.19	-0.83		-0.83	-0.73	0.47	-0.18	0.82	0.96	-0.7	-0.95	-0.4	-0.7	0.93	0.02	-0.65	0.83
Operating Income	0.09	-0.73	0.27	-0.85	0.8	0.17	0.46	-0.83		0.76	-0.51	0.49	-0.39	-0.86	0.79	0.86	0.35	0.79	-0.75	0.4	0.68	-0.59
Net Income From Continuing Ops	-0.31	-0.64	-0.13	-0.66	0.78	-0.18	0.44	-0.73	0.76		0.07	0.03	-0.49	-0.63	0.87	0.69	0.8	0.87	-0.74	0.57	0.92	-0.75
Research Development	-0.11	0.4	-0.51	0.63	-0.44	-0.33	-0.42	0.47	-0.51	0.07		-0.34	0.33	0.66	0.02	-0.51	0.53	0.02	0.47	0.34	-0.05	0.27
Ebitda	0.85	-0.21	0.25	-0.2	0.05	0.74	-0.02	-0.18	0.49	0.03	-0.34		0.34	-0.28	0.46	0.39	0.01	0.45	0.12	0.16	-0.15	0.25
Cost Of Revenue	0.67	0.65	0.43	0.79	-0.85	0.02	-0.91	0.82	-0.39	-0.49	0.33	0.34		0.75	-0.31	-0.69	-0.27	-0.32	0.88	0.38	-0.53	0.89
Total Operating Expenses	0.17	0.83	0.01	0.99	-0.95	-0.31	-0.83	0.96	-0.86	-0.63	0.66	-0.28	0.75		-0.64	-0.97	-0.26	-0.64	0.9	0.08	-0.62	0.8
Income Before Tax	0.1	-0.65	-0.22	-0.62	0.69	0.29	0.45	-0.7	0.79	0.87	0.02	0.46	-0.31	-0.64		0.78	0.82	1.0	-0.55	0.47	0.71	-0.56
Non Operating Income Net Other	-0.07	-0.84	-0.17	-0.95	0.93	0.43	0.83	-0.95	0.86	0.69	-0.51	0.39	-0.69	-0.97	0.78		0.43	0.78	-0.84	-0.03	0.62	-0.77
Total Other Income Expense Net	-0.2	-0.39	-0.54	-0.26	0.45	0.01	0.32	-0.4	0.35	0.8	0.53	0.01	-0.27	-0.26	0.82	0.43		0.82	-0.35	0.46	0.68	-0.51
Net Income	0.09	-0.65	-0.22	-0.63	0.69	0.28	0.45	-0.7	0.79	0.87	0.02	0.45	-0.32	-0.64	1.0	0.78	0.82		-0.56	0.47	0.72	-0.57
Tax Provision	0.53	0.77	0.08	0.94	-0.97	0.08	-0.8	0.93	-0.75	-0.74	0.47	0.12	0.88	0.9	-0.55	-0.84	-0.35	-0.56		-0.01	-0.78	0.94
Net Interest Income	0.15	-0.01	0.39	0.07	0.0	-0.44	-0.47	0.02	0.4	0.57	0.34	0.16	0.38	0.08	0.47	-0.03	0.46	0.47	-0.01		0.48	0.04
Interest Income	-0.47	-0.61	-0.01	-0.65	0.77	-0.26	0.47	-0.65	0.68	0.92	-0.05	-0.15	-0.53	-0.62	0.71	0.62	0.68	0.72	-0.78	0.48		-0.85
Reconciled Depreciation	0.63	0.73	0.27	0.83	-0.93	0.06	-0.84	0.83	-0.59	-0.75	0.27	0.25	0.89	0.8	-0.56	-0.77	-0.51	-0.57	0.94	0.04	-0.85

Click cells to compare fundamentals

Celularity Account Relationship Matchups

Celularity income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Ebit	(7.9M)	(210.6M)	(97.2M)	14.2M	16.3M	17.2M
Net Income Applicable To Common Shares	(211.9M)	(49.3M)	(100.1M)	14.2M	16.3M	17.1M
Income Tax Expense	668.2K	(4.7M)	20K	13K	15.0K	15.7K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Celularity Stock Analysis

When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Celularity Historical Income Statement

About Celularity Income Statement Analysis

Celularity Income Statement Chart

Total Revenue

Other Operating Expenses

Celularity income statement Correlations

Celularity Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Celularity income statement Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Celularity Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Interest Expense	Ebit
Net Income Applicable To Common Shares	Income Tax Expense
Depreciation And Amortization	Selling General Administrative
Selling And Marketing Expenses	Total Revenue
Gross Profit	Other Operating Expenses
Operating Income	Net Income From Continuing Ops
Research Development	Ebitda
Cost Of Revenue	Total Operating Expenses
Income Before Tax	Non Operating Income Net Other
Total Other Income Expense Net	Net Income
Tax Provision	Net Interest Income
Interest Income	Reconciled Depreciation

Net Income	+ 1.0	Income Before Tax
Total Operating Expenses	+ 0.99	Selling General Administrative
Other Operating Expenses	+ 0.97	Selling General Administrative
Total Operating Expenses	+ 0.96	Other Operating Expenses
Tax Provision	+ 0.94	Selling General Administrative
Reconciled Depreciation	+ 0.94	Tax Provision

Non Operating Income Net Other	- 0.97	Total Operating Expenses
Tax Provision	- 0.97	Selling And Marketing Expenses
Other Operating Expenses	- 0.97	Selling And Marketing Expenses
Selling And Marketing Expenses	- 0.97	Selling General Administrative
Non Operating Income Net Other	- 0.95	Other Operating Expenses
Total Operating Expenses	- 0.95	Selling And Marketing Expenses